Maruti Suzuki BUY. Performance Highlights. 4QFY2010 Result Update I Automobile

Similar documents
Colgate-Palmolive ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I FMCG

SpiceJet ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I Aviation

Bajaj Hindusthan NEUTRAL. Performance Highlights. 2QSY2010 Result Update I Sugar

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Tata Steel BUY. Performance Highlights. 3QFY2010 Result Update I Steel

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Zee News BUY. Performance Highlights. 3QFY2010 Result Update I Media

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Ambuja Cements NEUTRAL. Performance Highlights. Outlook and Valuation. 4QCY2009 Result Update I Cement

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Ultratech Cement ACCUMULATE. Performance Highlights. Outlook and Valuation: 3QFY2010 Result Update I Cement

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Century Plyboards Ltd

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Hindustan Media Ventures

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Hero MotoCorp NEUTRAL. Performance Highlights. CMP `2,245 Target Price - 4QFY2012 Result Update Automobile. Investment Period - Key financials

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Amber Enterprises India Ltd

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Procter & Gamble Hygiene & Health Care

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

BGR Energy Systems NEUTRAL. Performance Highlights CMP. `235 Target Price - 3QFY2013 Result Update Capital Goods. Investment Period -

MRF BUY. Performance Highlights. CMP `40,703 Target Price `47,548. 1QSY2015 Result Update Tyre

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

Apollo Tyres BUY. Performance Highlights. CMP Target Price `71 `82. 4QFY2011Result Update Tyre. Key financials (Consolidated)

Cadila Healthcare ACCUMULATE. Performance Highlights. CMP 860 Target Price QFY2013 Result Update Pharmaceutical. Key financials (Consolidated)

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Simplex Infrastructures

Advisory Desk. TVS Srichakra Ltd. BUY CMP. `355 Target Price `468. Investment rationale. Outlook and valuation. Investment Period 12 Months

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,797 Target Price `6,560. 3QFY2017 Result Update Automobile. 3-year price chart

JK Lakshmi Cement BUY. Performance Highlights CMP. `63 Target Price `79. 4QFY2012 Result Update Cement. Investment Period 12 Months

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

HT Media ACCUMULATE. Performance Highlights CMP. `102 Target Price `113. 3QFY2013 Result Update Media. Investment Period 12 months

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Cipla BUY. Performance Highlights CMP. `310 Target Price `369. 2QFY2012 Result Update Pharmaceutical. Investment Period 12 months

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Simplex Infrastructures

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Sesa Goa NEUTRAL. Performance Highlights CMP. `372 Target Price - 2QFY2011 Result Update Mining. Investment Period -

Apollo Tyres BUY. Performance Highlights. CMP Target Price `56 `65. 3QFY2011Result Update Tyre. Key Financials (Consolidated)

Cadila Healthcare 1QFY2011 Result Update

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `4,496 Target Price `4,960. 2QFY2016 Result Update Automobile. 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

SUN TV Network NEUTRAL. Performance Highlights CMP. `297 Target Price - 1QFY2013 Result Update Media. Investment Period -

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Lupin NEUTRAL. Performance Highlights CMP. `448 Target Price - 2QFY2011 Result Update Pharmaceutical. Investment Period -

ITD Cementation India

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Hindalco NEUTRAL. Performance highlights CMP. `112 Target Price - 1QFY2013 Result Update Base Metals. Investment Period -

Thermax NEUTRAL. Performance Highlights CMP. `673 Target Price - 3QFY2011 Results Update Capital Goods. Investment Period -

Sun Pharma NEUTRAL. Performance Highlights CMP. 1QFY2013 Result Update Pharmaceutical. `676 Target Price - Investment Period -

KEC International BUY. Performance Highlights. CMP Target Price `492 `648. 2QFY2011 Results Update Capital Goods. Key Financials (Consolidated)

Aurobindo Pharma BUY. Performance Highlights CMP. `109 Target Price `156. 1QFY2013 Result Update Pharmaceutical. Investment Period 12 months

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Container Corporation of India

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Transcription:

4QFY2010 Result Update I Automobile April 26, 2010 Maruti Suzuki Performance Highlights BUY CMP Target Price Rs1,335 Rs1,694 For 4QFY2010, Maruti Suzuki (Maruti) registered 31% yoy growth in Net Sales to Rs8,425cr (Rs6,433cr) and Net Profit of Rs657cr (Rs243cr), which were below our expectations. The company reported a good yoy performance on the Operating front owing to the substantial dip in Raw Material cost and improved Operating leverage. However, on a sequential basis, the company recorded around 193bp qoq decline in OPM, which came in lower than our expectation. We maintain a Buy on the stock. Performance below expectations, Volume drives growth: For 4QFY2010, Maruti reported Turnover of Rs8,425cr (Rs6,433cr), up 31% yoy, primarily on the back of a robust 21.5% yoy increase in Volume and 7.6% yoy jump in Average Realisations. OPM stood at 13.2% (7%) owing to the 329bp contraction in Raw Material costs, which accounted for 73.0% (76.2%) of Net Sales, and overall achieving optimum operating leverage. Maruti recorded Net Profit of Rs657cr (Rs243cr), which was below our expectation of Rs705cr. Outlook and Valuation: We remain positive on Maruti and expect it to register CAGR of 12.5% in overall Volumes over FY2010-12E aided by around 12.0% growth in Domestic Volumes and more than 20.0% growth in Export Volumes. We believe that the high growth potential of the Indian car market would mitigate the impact of rising competition for market leader Maruti Suzuki. However, higher commodity prices and increasing competition will restrict robust growth in Bottom-line. For FY2010-12E, we estimate the company s Top-line to record CAGR of 16.1% to and Net Profit to clock a CAGR of 11% following the dip in Operating Margins (due to higher input costs and advertising expenditure). We have marginally downgraded our EPS estimates for FY2011E to Rs93.3 (Rs96.6) and for FY2012E to Rs105.9 (Rs109.8). At the CMP, the stock is trading at 14.3x and 12.6x FY2011E and FY2012E Earnings, respectively. We maintain a Buy on Maruti, with a revised Target Price of Rs1,694 (Rs1,757), at which level the stock would trade at 16x FY2012E EPS. Investment Period 12 Months Stock Info Sector Automobile Market Cap (Rs cr) 38,571 Beta 0.7 52 WK High / Low 1,740/772 Avg. Daily Volume 142,845 Face Value (Rs) 5 BSE Sensex 17,745 Nifty 5,322 Reuters Code MRTI.BO Bloomberg Code MSIL@IN Shareholding Pattern (%) Promoters 54.2 MF/Banks/Indian FIs 22.3 FII/NRIs/OCBs 21.2 Indian Public 2.3 Abs. (%) 3m 1yr 3yr Sensex 5.7 56.6 24.7 Maruti (7.6) 66.4 67.5 Key Financials Y/E March (Rs cr) FY2009 FY2010E FY2011E FY2012E Net Sales 20,455 29,099 33,593 39,238 % chg 14.3 42.3 15.4 16.8 Net Profit 1,219 2,498 2,695 3,060 % chg (31.4) 104.9 7.9 13.5 OPM (%) 7.0 11.8 11.3 11.3 EPS (Rs) 37.1 86.4 93.3 105.9 P/E (x) 36.0 15.4 14.3 12.6 P/BV (x) 4.1 3.1 2.6 2.2 RoE (%) 15.7 16.5 19.2 17.8 RoCE (%) 7.4 22.3 20.0 19.7 EV/Sales (x) 1.5 1.0 0.8 0.7 EV/EBITDA (x) 23.8 9.7 8.3 6.7 Source: Company, Angel Research Vaishali Jajoo Tel: 022 4040 3800 Ext: 344 E-mail: vaishali.jajoo@angeltrade.com Please refer to important disclosures at the end of this report Sebi Registration No: INB 010996539 1

Exhibit 1: 4QFY2010 Performance Y/E March (Rs cr) 4QFY2010 4QFY2009 % chg FY2010 FY2009 % chg Net Sales (include Other Op. Inc.) 8,425 6,433 31.0 29,623 20,853 42.1 Consumption of RM 6,141 4,901 25.3 21,508 15,517 38.6 (% of Sales) 72.9 76.2 72.6 74.4 Staff Costs 153.4 133.1 15.2 545.6 471.1 15.8 (% of Sales) 1.8 2.1 1.8 2.3 Purchases of TG 272.2 180.3 51.0 905.0 725.6 24.7 (% of Sales) 3.2 2.8 3.1 3.5 Other Expenses 747.4 769.6 (2.9) 2,709.7 2,306.7 17.5 (% of Sales) 8.9 12.0 9.1 11.1 Total Expenditure 7,314 5,984 22.2 25,669 19,021 35.0 Operating Profit 1,111 449 147.3 3,954 1,832 115.8 OPM 13.2 7.0 13.3 8.8 Interest 12.9 8.9 44.9 33.5 51.0 (34.3) Depreciation 223.0 197.1 13.1 825.0 706.5 16.8 Other Income 79.0 105.4 (25.1) 496.8 601.3 (17.4) PBT (excl. Extr. Items) 954.1 348.7 173.6 3,593 1,676 114.4 Extr. Income/(Expense) 0.0 0.0-0.0 0.0 - PBT (incl. Extr. Items) 954.1 348.7 173.6 3,593 1,676 114.4 (% of Sales) 11.3 5.4 12.1 8.0 Provision for Taxation 297.6 105.6 181.8 1,094.9 457.1 139.5 (% of PBT) 31.2 30.3 30.5 27.3 Reported PAT 656.5 243.1 170.0 2,498 1,219 104.9 PATM 7.8 3.8 8.4 5.8 Equity capital (cr) 144.5 144.5 144.5 144.5 EPS (Rs) 22.7 8.4 170.0 86.4 42.2 104.9 Source: Company, Angel Research Performance below expectation: For 4QFY2010, Maruti recorded 31% jump in Net Sales to Rs8,425cr (including Service Income and Other Operating Income), which was below our expectation of Rs8,480cr. The Sales performance came on the back of the robust 21.5% yoy increase in Volumes, while average net realisation per vehicle moved up 7.6% yoy primarily due to the change in Sales mix. Exports registered a strong 67.1% yoy growth on the back of A-Star volumes driven by the European markets, recording Revenues of Rs1,283cr. Bottom-line grew 170% yoy to Rs657cr (Rs243cr) largely due to buoyant volumes on account of the spurt in demand in 4QFY2010, strong Exports, better Operating leverage and enhanced Product mix. Margins spurt yoy on high Volumes, optimum Operating leverage: During 4QFY2010, Maruti witnessed a 620bp yoy improvement in EBITDA Margins owing to improved Operating leverage largely due to favourable Product mix, Price variance and impact of Forex (Yen depreciation) on vendor imports, which circumvented the yoy increase in commodity prices. Staff costs and Other Expenditure dipped by 25bp and 309bp yoy in 4QFY2010, respectively. Overall, Maruti reported a stupendous 147% yoy increase in Operating Profit to Rs1,111cr (Rs449cr). However, on a sequential basis, the company reported 193bp qoq dip in OPM largely due to higher Raw material cost (on account of the cost of BS-IV upgradation) and higher advertising cost (incurred at the Auto Expo). In the coming quarters, management has guided that OPMs would be under pressure in view of the rising metal prices (steel, aluminum and copper). Unfavourable currency movements could also act as a risk to our Earning estimates going forward. April 26, 2010 2

Net Profit lower than estimated, surges 170%: Net Profit for the quarter increased a whopping 170% yoy to Rs656cr (Rs243cr) as against our expectation of Rs705cr. Depreciation increased 13.1% yoy to Rs223cr, with the company incurring Capex of around Rs1,300cr. Steady Tax provisioning was in line with estimates and robust Operating performance was complemented by healthy Top-line, which helped Maruti clock good growth for the quarter. Volume Performance: During the quarter, Maruti registered strong Volume growth both in the Domestic as well as Export markets. The company posted Total Sales Volume of 287,422 units during the quarter, up 21.5%. This included exceptional growth in Exports of a record 42,040 units, a yoy growth of 67.1%. Robust sales of A-Star and continued focus on tapping new market segments enabled the company achieve such a robust growth during the quarter. Management has guided on successfully developing an alternative Export strategy with 26 non-european markets panning out in their Export portfolio, which is expected to support continuing robust growth in the European markets going ahead for Maruti. Exhibit 2: 4QFY2010 Product Performance Segment / Model 4QFY10 4QFY09 % chg FY10 FY09 % chg A1 : Maruti 800 8,434 12,076 (30) 33,028 49,383 (33) C: Omni, Versa 32,466 21,421 52 101,325 77,948 30 A2: Alto, Wagon R, Zen, Swift, A-Star 173,683 152,645 14 633,190 511,396 24 A3 : SX4, Esteem,Dzire 29,702 23,228 28 99,315 75,928 31 Total Passenger cars 244,285 209,370 17 866,858 714,655 21 MUV: Gypsy, Vitara 1,097 2,115 (48) 3,932 7,489 (48) Domestic 245,382 211,485 16 870,790 722,144 21 Exports 42,040 25,153 67 147,557 70,023 111 Total Sales 287,422 236,638 22 1,018,347 792,167 29 Source: Company, Angel Research Exhibit 3: Passenger Vehicles Segment Volume Units 300,000 250,000 200,000 150,000 100,000 50,000 0 % 60 50 40 30 20 10 0 (10) (20) 1QFY2007 2QFY2007 3QFY2007 4QFY2007 1QFY2008 2QFY2008 3QFY2008 4QFY2008 1QFY2009 2QFY2009 3QFY2009 4QFY2009 1QFY2010 2QFY2010 3QFY2010 4QFY2010 Source: SIAM, Angel Research Market Share(RHS) Volume(LHS) % yoy growth(rhs) April 26, 2010 3

Capex plan and focus on R&D: The company continues to focus on long-term initiatives and its long-term capex plan of Rs9,000cr remains unchanged to be incurred over FY2008-12E. As per its initial plan, the company incurred capex of around Rs1,600cr in FY2009 and intends to invest another Rs2,800cr and Rs3,000cr in FY2010E and FY2011E, respectively. The Board of Directors have also approved investment towards capacity expansion at Manesar, which will entail capex of around Rs1,700cr leading to additional capacity of 250,000 cars per annum in addition to the current one million car capacity. The additional capacity will begin commercial production by 4QFY2012E. Management is focussed on R&D and investment in new and innovative products apart from keeping a check on selling and marketing expenditure in an intensifying competitive scenario. Passenger Car Industry: The Auto Expo 2010 unveiled a slew of new launches in the Passenger Car industry, particularly in the compact A2 Segment. Global manufacturers like Toyota (Etios to be launched by December 2010), Volkswagen (Polo launched in March 2010), General Motors (Chevrolet Beat launched at the Auto Expo) and Honda (Concept Car launch likely by December 2011) are geared to put forward attractively priced cars, which has to be looked as a threat to Maruti s market share over the next 3-4 years. In 4QFY2010, there was a spurt of new model launches by competitors at aggressive pricing levels. This eroded Maruti s market share from around 51% in 3QFY2010 to around 47% in 4QFY2010. However, management believes that the lower cost of ownership of its vehicles will offset competitors pricing tactics and lost market share will be regained. We believe that given its low penetration, the PV Segment has the potential to accommodate more competition and yet record double-digit growth over the next five years, and Maruti would continue its strong foothold in the car market as it has a sizeable competitive advantage over the new foreign entrants due to its widespread distribution network (service and sales outlets of around 2,767 and 802, respectively), which is not easy to replicate. Outlook and Valuation The PV Segment registered robust 26.9% yoy growth in FY2010 aided by the various stimulus packages announced by the government, improved business economic scenario and benign Interest rates following positive measures announced by the RBI and higher contribution from Export volumes. Further, lower penetration, favourable demographics and improving per capita would support around 12% CAGR in the PV Industry over the next 4-5 years. We believe that the high growth potential of the Indian car market would mitigate the impact of rising competition for market leader Maruti Suzuki. We remain positive on Maruti and expect it to register CAGR of 12.5% in overall Volumes over FY2010-12E aided by around 12% CAGR in Domestic Volumes and more than 20% CAGR in Export Volumes. We believe that the high growth potential of the Indian car market would mitigate the impact of rising competition for market leader Maruti Suzuki. However, higher commodity prices and increasing competition will restrict the company s robust growth in Bottom-line. For FY2010-12E, we estimate the company s Top-line to record CAGR of 16.1% to and Net Profit to clock CAGR of 11% following the dip in Operating Margins (due to higher input costs and advertising expenditure). We have marginally downgraded our EPS estimates for FY2011E to Rs93.3 (Rs96.6) and for FY2012E to Rs105.9 (Rs109.8). At the CMP, the stock is trading at 14.3x and 12.6x FY2011E and FY2012E Earnings, respectively. We maintain a Buy on Maruti, with a revised Target Price of Rs1,694 at which level the stock would trade at 16x FY2012E EPS. April 26, 2010 4

Exhibit 4: 1-year forward P/E Band Share Price (Rs) 1,800 1,500 1,200 900 600 300 16x 13x 10x 7x 0 Apr-04 Aug-04 Dec-04 Apr-05 Aug-05 Dec-05 Apr-06 Aug-06 Dec-06 Apr-07 Aug-07 Dec-07 Apr-08 Aug-08 Dec-08 Apr-09 Aug-09 Dec-09 Apr-10 Source: C-Line, Angel Research April 26, 2010 5

Profit & Loss Statement Rs crore Y/E March FY2007 FY2008 FY2009 FY2010 FY2011E FY2012E Net Sales 14,696 17,892 20,455 29,099 33,593 39,238 Total operating income 14,696 17,892 20,455 29,099 33,593 39,238 % chg - 21.7 14.3 42.3 15.4 16.8 Total Expenditure 12,706 15,598 19,020 25,669 29,781 34,804 Net Raw Materials 10,982 13,455 16,243 22,413 25,414 29,821 Other Mfg costs 250.9 345.1 0.0 0.0 772.6 863.2 Personnel 266.3 346.8 471.1 545.6 671.9 784.8 Other 1,207 1,451 2,307 2,710 2,923 3,335 EBITDA 1,990 2,294 1,435 3,430 3,812 4,434 % chg - 15.2 (37.4) 139.1 11.1 16.3 (% of Net Sales) 13.5 12.8 7.0 11.8 11.3 11.3 Depreciation& Amortisation 271.4 568.2 706.5 825.0 930.3 1,094.1 EBIT 1,719 1,726 728 2,605 2,881 3,340 % chg - 0.4 (57.8) 257.7 10.6 15.9 (% of Net Sales) 11.7 9.6 3.6 9.0 8.6 8.5 Interest & other Charges 37.6 59.6 51.0 33.5 34.9 34.9 Other Income 611 883 999 1,021 1,088 1,165 (% of PBT) 27.0 35.5 65.3 28.4 27.7 26.1 Recurring PBT 2,292 2,549 1,676 3,593 3,935 4,470 % chg - 11.2 (34.2) 114.4 9.5 13.6 Extraordinary Expense/(Inc.) (26.7) (61.1) (146.1) 0.0 0.0 0.0 PBT 2,265 2,488 1,530 3,593 3,935 4,470 Tax 718 772 457 1,095 1,239 1,410 (% of PBT) 32 31 30 30 32 32 PAT (reported) 1,574 1,777 1,219 2,498 2,695 3,060 ADJ. PAT 1,548 1,716 1,073 2,498 2,695 3,060 % chg 31.8 10.9 (37.5) 132.8 7.9 13.5 (% of Net Sales) 10.5 9.6 5.2 8.6 8.0 7.8 Basic EPS (Rs) 53.5 59.4 37.1 86.4 93.3 105.9 Fully Diluted EPS (Rs) 53.5 59.4 37.1 86.4 93.3 105.9 % chg 31.8 10.9 (37.5) 132.8 7.9 13.5 Balance Sheet Rs crore Y/E March FY2007 FY2008 FY2009 FY2010E FY2011E FY2012E SOURCES OF FUNDS Equity Share Capital 145 145 145 145 145 145 Preference Capital - - - - - - Reserves& Surplus 6,709 8,271 9,200 12,199 14,619 17,357 Shareholders Funds 6,854 8,415 9,345 12,344 14,763 17,501 Total Loans 631 900 699 699 699 699 Deferred Tax Liability 168 170 155 152 132 112 Total Liabilities 7,652 9,486 1,0199 13,194 15,594 18,312 APPLICATION OF FUNDS Gross Block 6,147 7,285 8,721 10,981 12,920 15,091 Less: Acc. Depreciation 3,487 3,989 4,650 5,475 6,405 7,499 Net Block 2,660 3,297 4,071 5,506 6,515 7,592 Capital Work-in-Progress 251 736 861 1,098 1,034 755 Goodwill - - - - - - Investments 3,409 5,181 3,173 5,278 6,238 7,325 Current Assets 4,405 3,098 5,491 5,983 7,205 8,739 Cash 1,423 331 1,939 850 1,538 2,353 Loans & Advances 1,533 1,074 1,731 2,619 2,855 3,139 Other 1,449 1,694 1,821 2,515 2,812 3,247 Current liabilities 3,072 2,826 3,398 4,671 5,398 6,099 Net Current Assets 1,333 272 2,094 1,312 1,807 2,640 Mis. Exp. not written off - - - - - - Total Assets 7,652 9,486 10,199 13,194 15,594 18,312 April 26, 2010 6

Cash Flow Statement Rs crore Y/E March FY2007 FY2008 FY2009 FY2010E FY2011E FY2012E Profit before tax 2,265 2,488 1,605 3,452 3,935 4,470 Depreciation 271 568 707 825 930 1,094 Change in Working Capital (596) (152) (403) (444) (401) (231) Less: Other income (829) 263 258 (167) (89) 339 Direct taxes paid 718 772 457 1,095 1,239 1,410 Cash Flow from Operations 2,052 1,869 1,193 2,905 3,313 3,583 (Inc.)/Dec. in Fixed Assets (1,351) (1,624) (1,560) (2,497) (1,875) (1,892) (Inc.)/Dec. in Investments (1,358) (1,772) 2,007 (2,104) (960) (1,087) (Inc.)/Dec. in loans and advances (75) 66 (40) (1,247) (169) (59) Other income 611 883 999 1,021 1,088 1,165 Cash Flow from Investing 3,394 4,213 592 6,869 4,092 4,203 Issue of Equity - - - - - - Inc./(Dec.) in loans 559 269 (201) - - - Dividend Paid (Incl. Tax) 115 152 169 118 203 254 Others 6,371 7,595 144 10,982 6,921 7,225 Cash Flow from Financing (5,697) (7,174) (176) (10,864) (6,718) (6,971) Inc./(Dec.) in Cash (250) (1,092) 1,609 (1,089) 688 815 Opening Cash balances 1,673 1,423 331 1,939 850 1,538 Closing Cash balances 1,423 331 1,939 850 1,538 2,353 Key Ratios Y/E March FY2007 FY2008 FY2009 FY2010E FY2011E FY2012E Valuation Ratio (x) P/E (on FDEPS) 24.9 22.5 36.0 15.4 14.3 12.6 P/CEPS 20.9 16.5 20.0 11.6 10.6 9.3 P/BV 5.6 4.6 4.1 3.1 2.6 2.2 Dividend yield (%) 0.3 0.4 0.3 0.4 0.6 0.7 EV/Sales 2.0 1.6 1.5 1.0 0.8 0.7 EV/EBITDA 17.3 14.8 23.8 9.7 8.3 6.7 EV / Total Assets 6.1 4.4 3.6 3.3 2.4 1.9 Per Share Data (Rs) EPS (Basic) 53.5 59.4 37.1 86.4 93.3 105.9 EPS (fully diluted) 53.5 59.4 37.1 86.4 93.3 105.9 Cash EPS 63.9 81.1 66.6 115.0 125.4 143.7 DPS 4.5 5.0 3.5 6.0 7.5 8.8 Book Value 237.2 291.2 323.4 427.1 510.8 605.6 Dupont Analysis EBIT margin 11.7 9.6 3.9 9.0 8.6 8.5 Tax retention ratio 0.7 0.7 0.7 0.7 0.7 0.7 Asset turnover (x) 5.9 5.3 4.5 4.8 4.5 4.8 ROIC (Post-tax) 47.3 35.0 12.7 29.8 26.5 27.8 Cost of Debt (Post Tax) 7.3 5.4 4.6 3.3 3.4 3.4 Leverage (x) 0.0 0.0 0.0 0.0 0.0 0.0 Operating ROE 47.3 35.0 12.7 29.8 26.5 27.8 Returns (%) ROCE (Pre-tax) 25.9 20.1 8.2 22.3 20.0 19.7 Angel ROIC (Pre-tax) 61.0 43.4 14.3 36.9 36.9 38.7 ROE 22.4 21.4 16.1 16.8 19.2 17.8 Turnover ratios (x) Asset Turnover (Gross Block) 2.6 2.7 2.6 3.0 2.8 2.8 Inventory / Sales (days) 19.7 17.7 17.3 13.8 15.1 14.9 Receivables (days) 17.3 14.3 14.0 15.2 14.6 14.0 Payables (days) 43.7 45.6 48.8 43.9 46.7 45.8 WC cycle (ex-cash) (days) (2.2) (1.5) 0.9 3.9 4.0 2.6 Solvency ratios (x) Net debt to equity (0.6) (0.5) (0.5) (0.4) (0.5) (0.5) Net debt to EBITDA (2.1) (2.0) (2.9) (1.6) (1.9) (2.0) Interest Coverage (EBIT / Interest) 45.7 29.0 15.8 77.8 82.5 95.6 April 26, 2010 7

Research Team Tel: 4040 3800 E-mail: research@angeltrade.com Website: www.angeltrade.com DISCLAIMER This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Securities Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, and is for general guidance only. Angel Securities Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Securities Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Securities Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Securities Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Disclosure of Interest Statement Maruti Suzuki 1. Analyst ownership of the stock Yes 2. Angel and its Group companies ownership of the stock No 3. Angel and its Group companies Directors ownership of the stock No 4. Broking relationship with company covered No Note: We have not considered any Exposure below Rs 1 lakh for Angel and its Group companies. Address: Acme Plaza, A Wing, 3rd Floor, M.V. Road, Opp. Sangam Cinema, Andheri (E), Mumbai - 400 059. Tel : (022) 3952 4568 / 4040 3800 Angel Broking Ltd: BSE Sebi Regn No : INB 010996539 / CDSL Regn No: IN - DP - CDSL - 234-2004 / PMS Regn Code: PM/INP000001546 Angel Securities Ltd:BSE: INB010994639/INF010994639 NSE: INB230994635/INF230994635 Membership numbers: BSE 028/NSE:09946 Angel Capital & Debt Market Ltd: INB 231279838 / NSE FNO: INF 231279838 / NSE Member code -12798 Angel Commodities Broking (P) Ltd: MCX Member ID: 12685 / FMC Regn No: MCX / TCM / CORP / 0037 NCDEX : Member ID 00220 / FMC Regn No: NCDEX / TCM / CORP / 0302 April 26, 2010 8